RECOMBINANT INFLUENZA ANTIGENS

The invention provides recombinant influenza A hemagglutinin (HA) polypeptides, comprising an HA1 and a HA2 domain of an influenza A virus HA, and comprising an amino acid sequence wherein:(a) the amino acid at position 355 is W; and(b) the amino acid at position 432 is I and/or the amino acid at po...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: JONGENEELEN, Mandy, Antonia, Catharina, LANGEDIJK, Johannes, Petrus, Maria, RITSCHEL, Tina, MILDER, Ferdinand, Jacobus, BRANDENBURG, Boerries, KING, Indigo, SONG, Yifan
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator JONGENEELEN, Mandy, Antonia, Catharina
LANGEDIJK, Johannes, Petrus, Maria
RITSCHEL, Tina
MILDER, Ferdinand, Jacobus
BRANDENBURG, Boerries
KING, Indigo
SONG, Yifan
description The invention provides recombinant influenza A hemagglutinin (HA) polypeptides, comprising an HA1 and a HA2 domain of an influenza A virus HA, and comprising an amino acid sequence wherein:(a) the amino acid at position 355 is W; and(b) the amino acid at position 432 is I and/or the amino acid at position 380 is I;and wherein the numbering of the amino acid positions in the amino acid sequence of the HA polypeptide is according to the numbering of amino acids in the amino acid sequence of HA from a reference H3N2 influenza strain, in particular the reference strain H3N2 A/Aichi/2/68 (SEQ ID NO: 1), immunogenic fragments thereof, nucleic acid molecules encoding said polypeptides or immunogenic fragments, and uses thereof.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP3959228A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP3959228A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP3959228A13</originalsourceid><addsrcrecordid>eNrjZJALcnX293Xy9HP0C1Hw9HPzCXX1i3JUAPI83V39gnkYWNMSc4pTeaE0N4OCm2uIs4duakF-fGpxQWJyal5qSbxrgLGlqaWRkYWjoTERSgCFHyEw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>RECOMBINANT INFLUENZA ANTIGENS</title><source>esp@cenet</source><creator>JONGENEELEN, Mandy, Antonia, Catharina ; LANGEDIJK, Johannes, Petrus, Maria ; RITSCHEL, Tina ; MILDER, Ferdinand, Jacobus ; BRANDENBURG, Boerries ; KING, Indigo ; SONG, Yifan</creator><creatorcontrib>JONGENEELEN, Mandy, Antonia, Catharina ; LANGEDIJK, Johannes, Petrus, Maria ; RITSCHEL, Tina ; MILDER, Ferdinand, Jacobus ; BRANDENBURG, Boerries ; KING, Indigo ; SONG, Yifan</creatorcontrib><description>The invention provides recombinant influenza A hemagglutinin (HA) polypeptides, comprising an HA1 and a HA2 domain of an influenza A virus HA, and comprising an amino acid sequence wherein:(a) the amino acid at position 355 is W; and(b) the amino acid at position 432 is I and/or the amino acid at position 380 is I;and wherein the numbering of the amino acid positions in the amino acid sequence of the HA polypeptide is according to the numbering of amino acids in the amino acid sequence of HA from a reference H3N2 influenza strain, in particular the reference strain H3N2 A/Aichi/2/68 (SEQ ID NO: 1), immunogenic fragments thereof, nucleic acid molecules encoding said polypeptides or immunogenic fragments, and uses thereof.</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220302&amp;DB=EPODOC&amp;CC=EP&amp;NR=3959228A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25562,76317</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220302&amp;DB=EPODOC&amp;CC=EP&amp;NR=3959228A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>JONGENEELEN, Mandy, Antonia, Catharina</creatorcontrib><creatorcontrib>LANGEDIJK, Johannes, Petrus, Maria</creatorcontrib><creatorcontrib>RITSCHEL, Tina</creatorcontrib><creatorcontrib>MILDER, Ferdinand, Jacobus</creatorcontrib><creatorcontrib>BRANDENBURG, Boerries</creatorcontrib><creatorcontrib>KING, Indigo</creatorcontrib><creatorcontrib>SONG, Yifan</creatorcontrib><title>RECOMBINANT INFLUENZA ANTIGENS</title><description>The invention provides recombinant influenza A hemagglutinin (HA) polypeptides, comprising an HA1 and a HA2 domain of an influenza A virus HA, and comprising an amino acid sequence wherein:(a) the amino acid at position 355 is W; and(b) the amino acid at position 432 is I and/or the amino acid at position 380 is I;and wherein the numbering of the amino acid positions in the amino acid sequence of the HA polypeptide is according to the numbering of amino acids in the amino acid sequence of HA from a reference H3N2 influenza strain, in particular the reference strain H3N2 A/Aichi/2/68 (SEQ ID NO: 1), immunogenic fragments thereof, nucleic acid molecules encoding said polypeptides or immunogenic fragments, and uses thereof.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJALcnX293Xy9HP0C1Hw9HPzCXX1i3JUAPI83V39gnkYWNMSc4pTeaE0N4OCm2uIs4duakF-fGpxQWJyal5qSbxrgLGlqaWRkYWjoTERSgCFHyEw</recordid><startdate>20220302</startdate><enddate>20220302</enddate><creator>JONGENEELEN, Mandy, Antonia, Catharina</creator><creator>LANGEDIJK, Johannes, Petrus, Maria</creator><creator>RITSCHEL, Tina</creator><creator>MILDER, Ferdinand, Jacobus</creator><creator>BRANDENBURG, Boerries</creator><creator>KING, Indigo</creator><creator>SONG, Yifan</creator><scope>EVB</scope></search><sort><creationdate>20220302</creationdate><title>RECOMBINANT INFLUENZA ANTIGENS</title><author>JONGENEELEN, Mandy, Antonia, Catharina ; LANGEDIJK, Johannes, Petrus, Maria ; RITSCHEL, Tina ; MILDER, Ferdinand, Jacobus ; BRANDENBURG, Boerries ; KING, Indigo ; SONG, Yifan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP3959228A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2022</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>JONGENEELEN, Mandy, Antonia, Catharina</creatorcontrib><creatorcontrib>LANGEDIJK, Johannes, Petrus, Maria</creatorcontrib><creatorcontrib>RITSCHEL, Tina</creatorcontrib><creatorcontrib>MILDER, Ferdinand, Jacobus</creatorcontrib><creatorcontrib>BRANDENBURG, Boerries</creatorcontrib><creatorcontrib>KING, Indigo</creatorcontrib><creatorcontrib>SONG, Yifan</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>JONGENEELEN, Mandy, Antonia, Catharina</au><au>LANGEDIJK, Johannes, Petrus, Maria</au><au>RITSCHEL, Tina</au><au>MILDER, Ferdinand, Jacobus</au><au>BRANDENBURG, Boerries</au><au>KING, Indigo</au><au>SONG, Yifan</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>RECOMBINANT INFLUENZA ANTIGENS</title><date>2022-03-02</date><risdate>2022</risdate><abstract>The invention provides recombinant influenza A hemagglutinin (HA) polypeptides, comprising an HA1 and a HA2 domain of an influenza A virus HA, and comprising an amino acid sequence wherein:(a) the amino acid at position 355 is W; and(b) the amino acid at position 432 is I and/or the amino acid at position 380 is I;and wherein the numbering of the amino acid positions in the amino acid sequence of the HA polypeptide is according to the numbering of amino acids in the amino acid sequence of HA from a reference H3N2 influenza strain, in particular the reference strain H3N2 A/Aichi/2/68 (SEQ ID NO: 1), immunogenic fragments thereof, nucleic acid molecules encoding said polypeptides or immunogenic fragments, and uses thereof.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre ; ger
recordid cdi_epo_espacenet_EP3959228A1
source esp@cenet
subjects CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title RECOMBINANT INFLUENZA ANTIGENS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T12%3A44%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=JONGENEELEN,%20Mandy,%20Antonia,%20Catharina&rft.date=2022-03-02&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP3959228A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true